Comparison of Outcomes With Multifocal Intraocular Lenses (COMIL)

December 6, 2023 updated by: A-Yong Yu, Wenzhou Medical University
The purpose of this study is to compare and evaluate the clinical outcomes of 6 kinds of Multifocal Intraocular Lenses: SN6AD1, SBL-3, LS-313 MF30, AT LISA tri 839 MP, ART, LS-313 MF30T.

Study Overview

Detailed Description

This study is a prospective randomized controlled trial to compare and evaluate the clinical outcomes of 6 kinds of Multifocal Intraocular Lenses, the outcome measurements include postoperative visual acuity, visual quality and complications. Patients enrolled in the study will be randomized to receive one of the Multifocal Intraocular Lenses mentioned above, and the clinical outcomes of each Multifocal Intraocular Lens will be assessed at several visits: 1 day, 1 week, 1 month, 3 months and months post-operatively.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang
      • Wenzhou, Zhejiang, China, 325000
        • Recruiting
        • The Eye Hispital of Wenzhou Medical University
        • Contact:
        • Sub-Investigator:
          • Shuangqian Zhu, MD.
        • Sub-Investigator:
          • Kaijing Zhou, MD.PhD.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age from 40 to 80 years old, either gender;
  • Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation;
  • Willing to undergo second eye surgery within 7 days after first eye surgery;
  • The potential postoperative visual acuity of 20/40 or better in both eyes;
  • Preoperative measurement of corneal astigmatism indicate the subjects are suitable for multifocal intraocular lenses implantation;
  • Capability to understand the informed consent and willing and able to attend study

Exclusion Criteria:

  • Preexisting ocular diseases or conditions other than age related cataracts, have contraindications for cataract surgery;
  • Preexisting systemic diseases or conditions that may confound the results of the study;
  • Previous ocular surgery history or ocular trauma that may confound the results of the study;
  • Require combined surgery that may confound the results of the study;
  • Previous participation in other clinical trial within 30 days of this study start;
  • Systemic or ocular medications that may confound the outcome of the intervention
  • Pregnant, lactating, or planning to become pregnant during the course of the trial;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: SN6AD1 group
Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs
Bilateral cataract surgery with implantation of SN6AD1 multifocal IOLs
Active Comparator: SBL-3 group
Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs
Bilateral cataract surgery with implantation of SBL-3 multifocal IOLs
Active Comparator: LS-313 MF30 group
Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs
Bilateral cataract surgery with implantation of LS-313 MF30 multifocal IOLs
Active Comparator: AT LISA tri 839 MP group
Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs
Bilateral cataract surgery with implantation of AT LISA tri 839 MP multifocal IOLs
Active Comparator: ART group
Bilateral cataract surgery with implantation of ART toric multifocal IOLs
Bilateral cataract surgery with implantation of ART toric multifocal IOLs
Active Comparator: LS-313 MF30T group
Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs
Bilateral cataract surgery with implantation of LS-313 MF30T toric multifocal IOLs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Uncorrected Visual Acuity (UCVA) at Distance, Near
Time Frame: 3 months after surgery
3 months after surgery
Best distance corrected Visual Acuity at Distance, Near
Time Frame: 3 months after surgery
3 months after surgery
Defocus curve
Time Frame: 3 months after surgery
measured with distance correction for unilateral and bilateral
3 months after surgery
Contrast sensitivity
Time Frame: 3 months after surgery
measured with CSV-1000HGT(VECTOR VISION, Greenville, OH)
3 months after surgery
Ocular aberration
Time Frame: 3 months after surgery
measured with a custom-built aberrometer
3 months after surgery
Ocular Scatter Index measured by Optical Quality Analysis System(OQAS) II
Time Frame: 3 months after surgery
3 months after surgery
Modulation Transfer Function (MTF) cut-off measured by OQAS II
Time Frame: 3 months after surgery
3 months after surgery
Strehl Ratio measured by OQAS II
Time Frame: 3 months after surgery
3 months after surgery
Quality of Vision (QoV) Questionnaire score
Time Frame: 3 months after surgery
3 months after surgery
Catquest- 9SF Questionnaire score
Time Frame: 3 months after surgery
3 months after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Refractive error after surgery
Time Frame: 3 months after surgery
3 months after surgery
Rate of Posterior Capsule Opacification
Time Frame: 6 months after surgery
6 months after surgery
Rate of Nd:YAG Laser Posterior Capsulotomy
Time Frame: 6 months after surgery
6 months after surgery
Rate of Spectacle Independence
Time Frame: 6 months after surgery
6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: AYong Yu, MD. PhD., Wenzhou Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

February 1, 2016

First Submitted That Met QC Criteria

February 7, 2016

First Posted (Estimated)

February 10, 2016

Study Record Updates

Last Update Posted (Estimated)

December 7, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MIOLs2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on SN6AD1

3
Subscribe